Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic Dermatitis

PHASE3CompletedINTERVENTIONAL
Enrollment

728

Participants

Timeline

Start Date

October 28, 2021

Primary Completion Date

February 29, 2024

Study Completion Date

March 7, 2024

Conditions
Atopic Dermatitis
Interventions
DRUG

Tapinarof cream, 1%

Tapinarof cream, 1%, applied daily to affected areas by subjects or their caregivers based on vIGA-AD. Subjects are advised to choose the application time they prefer and apply the study drug at that approximate time each day of study participation.

Trial Locations (112)

10075

Dermavant Investigative Site, New York

11530

Dermavant Investigative Site, Garden City

20037

Dermavant Investigative Site, Washington D.C.

20774

Dermavant Investigative Site, Largo

20850

Dermavant Investigative Site, Rockville

23226

Dermavant Investigative Site, Richmond

28277

Dermavant Investigative Site, Charlotte

29303

Dermavant Investigative Site, Spartanburg

29420

Dermavant Investigative Site, North Charleston

29445

Dermavant Investigative Site, Mt. Pleasant

29615

Dermavant lnvestigative Site, Greenville

29621

Dermavant Investigative Site, Anderson

30060

Dermavant Investigative Site, Marietta

30078

Dermavant Investigative Site, Snellville

30328

Dermavant Investigative Site, Sandy Springs

31406

Dermavant Investigative Site, Savannah

32256

Dermavant Investigative Site, Jacksonville

32801

Dermavant Investigative Site, Orlando

33014

Dermavant Investigative Site, Miami Lakes

33016

Dermavant Investigative Site, Hialeah

33063

Dermavant Investigative Site, Margate

33146

Dermavant Investigative Site, Coral Gables

33165

Dermavant Investigative Site, Miami

33172

Dermavant Investigative Site, Sweetwater

33173

Dermavant Investigative Site, Miami

33428

Dermavant Investigative Site, Boca Raton

33484

Dermavant Investigative Site, Delray Beach

33486

Dermavant Investigative Site, Boca Raton

33511

Dermavant Investigative Site, Brandon

33607

Dermavant Investigative Site, Tampa

33781

Dermavant Investigative Site, Pinellas Park

35244

Dermavant Investigative Site, Birmingham

37909

Dermavant Investigative Site, Knoxville

38119

Dermavant Investigative Site, Memphis

40217

Dermavant Investigative Site, Louisville

40241

Dermavant Investigative Site, Louisville

40517

Dermavant Investigative Site, Lexington

42301

Dermavant Investigative Site, Owensboro

43209

Dermavant Investigative Site, Bexley

44106

Dermavant Investigative Site, Cleveland

44124

Dermavant Investigative Site, Mayfield Heights

45040

Dermavant Investigative Site, Mason

45414

Dermavant Investigative Site, Dayton

46168

Dermavant Investigative Site, Plainfield

47715

Dermavant Investigative Site, Evansville

48088

Dermavant Investigative Site, Warren

48197

Dermavant Investigative Site, Ypsilanti

48346

Dermavant Investigative Site, Clarkston

48706

Dermavant Investigative Site, Bay City

55112

Dermavant Investigative Site, New Brighton

59808

Dermavant Investigative Site, Missoula

60611

Dermavant Investigative Site, Chicago

66210

Dermavant Investigative Site, Overland Park

68144

Dermavant Investigative Site, Omaha

70115

Dermavant Investigative Site, New Orleans

70433

Dermavant Investigative Site, Covington

70808

Dermavant Investigative Site, Baton Rouge

70809

Dermavant Investigative Site, Baton Rouge

71201

Dermavant Investigative Site, Monroe

72022

Dermavant Investigative Site, Bryant

72916

Dermavant Investigative Site, Fort Smith

73071

Dermavant Investigative Site, Norman

73120

Dermavant Investigative Site, Oklahoma City

74114

Dermavant Investigative Site, Tulsa

75230

Dermavant Investigative Site, Dallas

76051

Dermavant Investigative Site, Grapevine

77004

Dermavant Investigative Site, Houston

77401

Dermavant Investigative Site, Bellaire

77433

Dermavant Investigative Site, Cypress

77479

Dermavant Investigative Site, Sugar Land

77598

Dermavant Investigative Site, Webster

78213

Dermavant Investigative Site, San Antonio

78218

Dermavant Investigative Site, San Antonio

78229

Dermavant Investigative Site, San Antonio

78620

Dermavant Investigative Site, Dripping Springs

80112

Dermavant Investigative Site, Thornton

85032

Dermavant Investigative Site, Phoenix

85255

Dermavant Investigative Site, Scottsdale

85260

Dermavant Investigative Site, Scottsdale

90017

Dermavant Investigative Site, Los Angeles

90033

Dermavant Investigative Site, Los Angeles

90045

Dermavant Investigative Site, Los Angeles

90301

Dermavant Investigative Site, Inglewood

90404

Dermavant Investigative Site, Santa Monica

90702

Dermavant Investigative Site, Cerritos

90806

Dermavant Investigative Site, Long Beach

91320

Dermavant Investigative Site, Thousand Oaks

92123

Dermavant Investigative Site, San Diego

92647

Dermavant Investigative Site, Huntington Beach

92691

Dermavant Investigative Site, Mission Viejo

92701

Dermavant Investigative Site, Santa Ana

92708

Dermavant Investigative Site, Fountain Valley

93534

Dermavant Investigative Site, Lancaster

94115

Dermavant Investigative Site, San Francisco

94538

Dermavant Investigative Site, Fremont

95815

Dermavant Investigative Site, Sacramento

97210

Dermavant Investigative Site, Portland

97223

Dermavant Investigative Site, Portland

97239

Dermavant Investigative Site, Portland

97504

Dermavant Investigative Site, Medford

99202

Dermavant Investigative Site, Spokane

08520

Dermavant Investigative Site, East Windsor

T3A 2N1

Dermavant Investigative Site, Calgary

V3R 6A7

Dermavant Investigative Site, Surrey

R3M 3Z4

Dermavant Investigative Site, Winnipeg

L4M 7G1

Dermavant Investigative Site, Barrie

K9A 0Z4

Dermavant Investigative Site, Cobourg

L6J 7W5

Dermavant Investigative Site, Oakville

K2C 3N2

Dermavant Investigative Site, Ottawa

N2J 7G1

Dermavant Investigative Site, Waterloo

N8W 1E6

Dermavant Investigative Site, Windsor

H2X 2V1

Dermavant Investigative Site, Montreal

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT05142774 - Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic Dermatitis | Biotech Hunter | Biotech Hunter